Joseph W Lewcock

22PUBLICATIONS
182CO-AUTHORS
Gene and molecular therapyInnate immunityMedical virologyMedical infection agents (incl. prions)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Apr 15, 2026
Author Correction: Fc-engineered large molecules targeting blood-brain barrier transferrin receptor and CD98hc have distinct central nervous system and peripheral biodistribution.

|Feb 16, 2026
Therapeutic targeting of neuroimmune mechanisms in neurodegeneration.

Kathryn M Monroe, Soyon Hong, Joseph W Lewcock

|Jan 24, 2026
TREM2 expression level is critical for microglial state, metabolic capacity and efficacy of TREM2 agonism.

Astrid F Feiten, Kilian Dahm, Kai Schlepckow

|Dec 03, 2025
Loss of PILRA promotes microglial immunometabolism to reduce amyloid pathology in cell and mouse models of Alzheimer's disease.

Tanya N Weerakkody, Hanna Sabelström, Shan V Andrews

|Aug 18, 2025
Investigational eIF2B activator DNL343 modulates the integrated stress response in preclinical models of TDP-43 pathology and individuals with ALS in a randomized clinical trial.

Brittany N Flores, Seungyoon B Yu, Isaac V Cohen

|Aug 07, 2025
Transferrin receptor-targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA.

Michelle E Pizzo, Edward D Plowey, Nathalie Khoury

Pageof 4

Frequent Collaborators

7 joint publications

Michelle Pizzo

6 joint publications

Johann Chow

6 joint publications

Meredith E K Calvert

6 joint publications

David Joy